MedPath

â??Evaluation of Shirodhara with Amalaki Kwatha in Patient of Anxiety Neurosisâ??

Phase 2
Completed
Conditions
Health Condition 1: J40- Bronchitis, not specified as acuteor chronic
Registration Number
CTRI/2017/11/010413
Lead Sponsor
Central Council For Research in Ayurvedic Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

2.Patients of GAD more than 6 months

3.Hamiltonâ??s Anxiety Rating Scale (HAM-A) > 18

4.Known cases of GAD having 3 or more symptoms of: excessive worry, restlessness, fatigue, concentration problem, irritability, muscle tension, sleep disturbance; of more than 6 months duration.

5.Anxiety screening scale GAD-7 of >10 score.

Exclusion Criteria

1.Hypertension, Diabetes, Hyperthyroidism, H/O Cardiovascular disease

2.H/o any co-morbid condition of personality disorder, eating disorder, Depression, and Bipolar disorder and major psychiatric illness.

3.Any other condition which the Investigator thinks may jeopardize the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Hamiltons Anxiety Scale Total score from baseline to 14th day and 28th day <br/ ><br> <br/ ><br>Timepoint: 14DAYS
Secondary Outcome Measures
NameTimeMethod
1.Any change in Psychic anxiety scale from baseline to 14th day and 28th day. <br/ ><br>2.Any change in Somatic anxiety scale from baseline to 14th day and 28th day. <br/ ><br>3.Any 50% reduction on total score value from baseline to 14th day and 28th day.Timepoint: 28DAYS
© Copyright 2025. All Rights Reserved by MedPath